Neurocrine Biosciences EBIT 2010-2024 | NBIX
- Neurocrine Biosciences 2023 EBIT was 0.251B, a 0.76% increase from 2022.
- Neurocrine Biosciences 2022 EBIT was 0.249B, a 142.93% increase from 2021.
- Neurocrine Biosciences 2021 EBIT was 0.103B, a 37.12% decline from 2020.
EBIT can be defined as earnings before interest and taxes.